Your Article Summary
See Latest ArticlesClinical Application of Cordyceps sinensis on Immunosuppressive Therapy in Renal Transplantation
Transplantation Proceedings, 06/25/09
Li Y et al. - The use of CS may allow decreased dosages and concentrations of CsA causing fewer side effects without an increased risk of acute rejection. In addition, CS with reduced dose CsA may decrease proteinuria and retard CAN progression.
Related Articles
Using Complementary and Alternative Medicines to Target the Host Response during Severe Influenza
Evidence-based Complementary and Alternative Medicine, 10/05/09
Relevance Score: 39%
Today in Kidney...keeping you current
Receive free subspecialty "5-minute updates" via email
Renal Insufficiency is an Independent Risk Factor for Complications After Partial Nephrectomy
The Journal of Urology, 12/10/09
Should Patients With Primary Upper Urinary Tract Cancer Receive Prophylactic Intravesical Chemotherapy After Nephroureterectomy
The Journal of Urology, 12/10/09
Preventive effects of COX-2 inhibitor, celecoxib on renal tubular injury induced by shock wave lithotriptor
Urological Research - Urolithiasis, 12/10/09
Today in Transplantation...keeping you current
Receive free subspecialty "5-minute updates" via email
Successful DCD Kidney Transplantation Using Early Corticosteroid Withdrawal
American Journal of Transplantation, 12/09/09
Long-term outcome of focal segmental glomerulosclerosis after pediatric renal transplantation
Pediatric Nephrology, 12/09/09
Calculated PRA (CPRA): The New Measure of Sensitization for Transplant Candidates
American Journal of Transplantation, 12/09/09